The AM COVID19/FluAB/RSV Quality Controls are intended for use by clinical labs and assay manufacturers to assess the performance of any molecular-based testing of SARS-COV-2, Influenza A/B, Respiratory Syncytial Virus (RSV) A and B.
The Control contain a non-pathogenic recombinant RNA virus carrying full-length of SARS-COV-2, Segment 7 and 8 of Influenza A&B (M and NS genes), and the most conserved regions on RSV A & B. Please contact us for detailed information.
Anchor SARS-COV-2 Reference Panel
Part Number: 60230002
4 Vials of positives and 1 vial of negative
(0, 1000, 10,000, 100,000 and 1,000,000 copies/ml,
Negative has 10,000 copy/ml human gDNA),
1 mL Fill Volume, -20°C Storage
Does your cfDNA extraction process affect the Limit of Detection (LOD) of a particular gene target? Our new products, cfDNA Extraction Sensitivity Panels and Extraction Low Positive Controls, can help your research and development for liquid biopsy assays.
Build your own controls using your high-positive samples to save time. With our DNA-depleted human plasma (DNA-free plasma) as a matrix, you can produce reference materials specific to your time-sensitive needs while retaining the natural components of the sample.
The Plasma Genomic cfDNA Extraction Control is for the purpose of monitoring the degree of genomic DNA (gDNA) contamination in the extracted cfDNA. DNA-free plasma is spiked with either with high molecular weight gDNA molecules or 170 bp cfDNA fragments or both.